Stroke genetics informs drug discovery and risk prediction across ancestries (vol 611, pg 115, 2022)

被引：4

作者：

Mishra, Aniket

Malik, Rainer

Hachiya, Tsuyoshi

Jurgenson, Tuuli

Namba, Shinichi

Posner, Daniel C.

Kamanu, Frederick K.

Koido, Masaru

Le Grand, Quentin

Shi, Mingyang

He, Yunye

Georgakis, Marios K.

Caro, Ilana

Krebs, Kristi

Liaw, Yi-Ching

Vaura, Felix C.

Lin, Kuang

Winsvold, Bendik Slagsvold

Srinivasasainagendra, Vinodh

Parodi, Livia

Bae, Hee-Joon

Chauhan, Ganesh

Chong, Michael R.

Tomppo, Liisa

Akinyemi, Rufus

Roshchupkin, Gennady V.

Habib, Naomi

Jee, Yon Ho

Thomassen, Jesper Qvist

Abedi, Vida

Carcel-Marquez, Jara

Nygaard, Marianne

Leonard, Hampton L.

Yang, Chaojie

Yonova-Doing, Ekaterina

Knol, Maria J.

Lewis, Adam J.

Judy, Renae L.

Ago, Tetsuro

Amouyel, Philippe

Armstrong, Nicole D.

Bakker, Mark K.

Bartz, Traci M.

Bennett, David A.

Bis, Joshua C.

Bordes, Constance

Borte, Sigrid

Cain, Anael

Ridker, Paul M.

Cho, Kelly

机构：

来源：

NATURE | 2022年 / 612卷 / 7938期

关键词：

D O I：

10.1038/s41586-022-05492-5

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：E7 / E7

页数：1

共 44 条

[41] ADME evaluation in drug discovery. 2. Prediction of partition coefficient by atom-additive approach based on atom-weighted solvent accessible surface areas (vol 43, pg 1058, 2003)
Hou, TJ
Xu, XJ
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (04): : 1516 - 1516
[42] Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies (vol 15, pg 1238, 2016)
Kelly, P. J.
Albers, G. W.
Chatzikonstantinou, A.
LANCET NEUROLOGY, 2016, 15 (13): : 1301 - 1301
[43] RETRACTED: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug (Retracted article. See vol. 76, pg. 5991, 2022)
Rabie, Amgad M.
CHEMICAL PAPERS, 2021, 75 (09) : 4669 - 4685
[44] Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants? (vol 1, pg 83, 2015)
Goto, S.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (04) : 217 - 217

← 1 2 3 4 5 →